Kineta Invited to Participate at the Cowen and Company 40th Annual Health Care Conference Seattle, WA -- (February 26, 2020) Kineta, Inc., a clinical stage biotechnology company focused on the develo ...

Kineta Invited to Participate at the BIO CEO & Investor Conference Seattle, WA -- (February 5, 2020) Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immun ...

Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference Seattle, WA -- (November 26, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development o ...

Kineta Invited to Participate at October 2019 Investor Conferences Seattle, WA -- (October 7, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunother ...

Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference Seattle, WA -- (August 28, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the deve ...

Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference Seattle, WA -- (August 12, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development ...

Kineta Secures $1.8 Million Funding Boost from Wellcome Trust on Positive Phase 1a Clinical Study Results with LHF-535 Favorable overall safety, tolerability, and pharmacokinetic profile of LHF-535 f ...

Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses Seattle, WA -- (July 15, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the development of nove ...